Agency Forms Undergoing Paperwork Reduction Act Review, 26760-26762 [2014-10618]
Download as PDF
<![CDATA[
26760
Federal Register / Vol. 79, No. 90 / Friday, May 9, 2014 / Notices
EARLY TERMINATIONS GRANTED—Continued
APRIL 1, 2014 THRU APRIL 30, 2014
04/22/2014
20140722
20140741
20140755
20140779
20140794
......
......
......
......
......
G
G
G
G
G
Aceto Corporation; Pack Pharmaceuticals, LLC; Aceto Corporation.
Concordia Healthcare Corp.; Paul B. Manning; Concordia Healthcare Corp.
L. John Doerr; Essence Group Holdings Corporation; L. John Doerr.
Mr. Mark Zuckerberg; Oculus YR. Inc.; Mr. Mark Zuckerberg.
SiTV Media, Inc.; The Madison Square Garden Company; SiTV Media, Inc.
04/23/2014
20140783 ......
20140787 ......
G
G
Stratasys Ltd.; Joseph Allison; Stratasys Ltd.
Joseph Allison; Stratasys Ltd.; Joseph Allison.
04/24/2014
20140728 ......
G
Catholic Health Initiatives; Memorial Health System of East Texas; Catholic Health Initiatives.
04/25/2014
20140743
20140785
20140804
20140805
......
......
......
......
G
G
G
G
SCF–VII, L.P.; RedZone Coil Tubing, LLC; SCF–VII, L.P.
The Westaim Corporation; Houston International Insurance Group, Ltd.; The Westaim Corporation.
ASP VI Alternative Investments, L.P.; Wayzata Opportunities Fund II, L.P.; ASP VI Alternative Investments, L.P.
ON Semiconductor Corporation; Platinum Equity Capital Partners II, L.P.; ON Semiconductor Corporation.
04/28/2014
20140792 ......
20140811 ......
20140812 ......
G
G
G
Lone Star Fund VIII (Bermuda), L.P.; DFC Global Corp.; Lone Star Fund VIII (Bermuda), L.P.
Northwestern Corporation; PPL Corporation; Northwestern Corporation.
American Securities Partners VI, L.P.; Morgan Stanley; American Securities Partners VI, L.P.
04/29/2014
20140777 ......
20140781 ......
G
G
SAP AG; Madison Dearborn Capital Partners VI–A, L.P.; SAP AG.
Intel Corporation; Cloudera, Inc.; Intel Corporation.
04/30/2014
20140749 ......
20140824 ......
20140827 ......
G
G
G
Celgene Corporation; Acceleron Phanna, Inc.; Celgene Corporation.
TreeHouse Foods, Inc.; PFF Capital Group, Inc.; TreeHouse Foods, Inc.
York Special Opportunities Fund II–A, L.P.; Fillmore WAC Management Investment, LLC; York Special Opportunities Fund
II–A, L.P.
For Further Information Contact:
Renee Chapman, Contact Representative
or Theresa Kingsberry, Legal Assistant.
Federal Trade Commission, Premerger
Notification Office, Bureau of
Competition, Room H–303, Washington,
DC 20580, (202) 326–3100.
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. 2014–10645 Filed 5–8–14; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
ehiers on DSK2VPTVN1PROD with NOTICES
Centers for Disease Control and
Prevention
[30Day–14–0904]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
VerDate Mar<15>2010
14:53 May 08, 2014
Jkt 232001
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
SEARCH for Diabetes in Youth Study
(OMB No. 0920–0904, exp. 11/30/
2014)—Revision—National Center for
Chronic Disease Prevention and Health
E:\FR\FM\09MYN1.SGM
09MYN1
26761
Federal Register / Vol. 79, No. 90 / Friday, May 9, 2014 / Notices
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Diabetes is one of the most common
chronic diseases among children in the
United States. Reports of increasing
frequency of both type 1 and type 2
diabetes in youth have been among the
most concerning aspects of the evolving
diabetes epidemic. In response to this
growing public health concern, the
Centers for Disease Control and
Prevention (CDC) and the National
Institutes of Health (NIH) funded the
SEARCH for Diabetes in Youth Study.
The SEARCH for Diabetes in Youth
Study began in 2000 as a multi-center,
epidemiological study, conducted in six
geographically dispersed clinical study
centers that reflected the racial and
ethnic diversity of the U.S. Phases 1
(2000–2005) and 2 (2005–2010)
produced estimates of the prevalence
and incidence of diabetes among youth
age <20 years, according to diabetes
type, age, sex, and race/ethnicity, and
characterized selected acute and chronic
complications of diabetes and their risk
factors, as well as the quality of life and
quality of health care. In Phases 1 and
2, the clinical centers and a data
coordinating center were funded
through cooperative agreements. The
information collected at that time was
not provided directly to CDC.
Phase 3 (2011–present) builds upon
previous efforts. Five clinical sites
collect patient-level information that is
compiled by a data coordinating center.
CDC obtained OMB approval to receive
the information in 2011 (SEARCH for
Diabetes in Youth, OMB No. 0920–0904,
exp. 11/30/2014). Phase 3 includes a
case registry of youth <20 years of age
who have been diagnosed with diabetes,
and a longitudinal cohort research study
about SEARCH cases whose diabetes
was incident in 2002 or later. To date,
SEARCH Phase 3 has identified an
average of 1,361 incident cases of
diabetes among youth under 20 years
each year of the study and has
completed an average of 1,088
participant surveys each year (80%
participation rate among registry study
participants). As of November 2013,
SEARCH Phase 3 has completed visits
for 1,839 cohort study participants.
CDC plans to continue information
collection for two additional years, with
minor changes. Participants in the
registry study will continue to complete
a Medication Inventory and an Initial
Participant Survey; however, the inperson study examination will be
discontinued. This change will result in
a decrease in burden per respondent.
CDC estimates that each clinical site
will identify and register an average of
255 cases per year, for a total 1,275
cases across all sites.
No data collection changes are
planned for the cohort study. CDC
estimates that each clinical site will
conduct follow-up on an average of 142
cases per year, for a total of 710 cases
across all sites. The items collected for
each case include a Health
Questionnaire (Youth version), an
additional Health Questionnaire (Parent
version), Center for Epidemiologic
Study-Depression, Quality of Care,
Pediatric Quality of Life Survey (Peds
QL), SEARCH Michigan Neuropathy
Screening Instrument, Diabetes Eating
Survey, Low Blood Sugar Survey,
Supplemental Survey, Tanner Stage,
Retinal Photo, Family Conflict Survey,
Pediatric Diabetes Quality of Life Scale,
Physical Exam, Specimen Collection,
and Food Frequency Questionnaire.
Findings from the registry study will
be used to estimate the incidence of
diabetes in youth in the U.S. Findings
from the cohort study will be used to
estimate the prevalence and incidence
of risk factors and complications
associated with diabetes in youth,
including chronic microvascular
complications (retinopathy,
nephropathy, and autonomic
neuropathy) and selected markers of
macrovascular complications
(hypertension, arterial stiffness) of
diabetes.
Participation is voluntary and there
are no costs to respondents other than
their time. The total estimated
annualized burden hours are 4,248.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
SEARCH Registry Study Participants ............
Medication Inventory ......................................
Initial Participant Survey ................................
Health Questionnaire-Youth ...........................
Health Questionnaire-Parent ..........................
CES-Depression .............................................
Quality of Care ...............................................
Peds QL .........................................................
SEARCH MNSI Neuropathy ..........................
Diabetes Eating Survey .................................
Low Blood Sugar Survey ...............................
Supplemental Survey .....................................
Tanner Stage .................................................
Retinal Photo ..................................................
Family Conflict Survey ...................................
Pediatric Diabetes QOL Scale .......................
Physical Exam ................................................
Specimen Collection ......................................
Food Frequency Questionnaire .....................
ehiers on DSK2VPTVN1PROD with NOTICES
SEARCH Cohort Study Participants ...............
VerDate Mar<15>2010
14:53 May 08, 2014
Jkt 232001
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
E:\FR\FM\09MYN1.SGM
Number of
responses per
respondent
1,275
1,275
710
710
710
710
710
710
710
710
710
710
710
710
710
710
710
710
09MYN1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Average
burden per
response
(in hr)
5/60
10/60
15/60
15/60
4/60
13/60
5/60
10/60
5/60
5/60
10/60
5/60
15/60
5/60
5/60
3
20/60
20/60
26762
Federal Register / Vol. 79, No. 90 / Friday, May 9, 2014 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–10618 Filed 5–8–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Agency Forms Undergoing Paperwork
Reduction Act Review
Proposed Project
Ready CDC—New—Office of Public
Health Preparedness and Response
(OPHPR), Centers for Disease Control
and Prevention (CDC).
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
Background and Brief Description
Under the Authority of Section 301 of
the Public Health Service Act (42 U.S.C.
241), the Centers for Disease Control
and Prevention is responsible for
administering the Ready CDC program.
Ready CDC is an educational
intervention designed to increase
awareness about personal and family
preparedness and increase the number
individuals who are prepared for a
disaster in their community. As a
response agency, CDC is responsible for
responding to national and international
disasters. One component of ensuring
staff are prepared to respond to disasters
is ensuring that the workforce has their
personal and family preparedness plans
in place. Research has shown that
individuals are more likely to respond
to an event if they perceive that their
family is prepared to function in their
absence during an emergency.
The Ready CDC educational
intervention consists of a Personal
Preparedness Workshop as well as three
targeted communications to reinforce
concepts discussed during the
workshop. A pilot program has already
been implemented, targeting only CDC
federal employees with a responder
role. The audience for this proposed
intervention will be all CDC employees,
including both federal staff and
contractors.
CDC requests Office of Management
and Budget (OMB) approval for three
[30Day–14–14IZ]
years to collect information that will
measure the initial preparedness of
participants, satisfaction with the
Personal Preparedness Workshops, and
the change in individual knowledge and
behaviors related to personal and family
preparedness.
CDC has developed three data
collection instruments: (1) PreWorkshop Survey; (2) Ready CDC
Workshop Evaluation; and (3) FollowUp Survey. Collectively, these
instruments are needed to gather,
process, aggregate, evaluate, and
disseminate information describing the
program’s processes and outcomes. The
information will be used by CDC to
document progress toward meeting
established program goals and
objectives, to evaluate outcomes
generated by the Ready CDC Personal
Preparedness Workshops and to
respond to data inquiries made by other
agencies of the federal government.
Survey instrument questions will
gather perceptions about personal and
regional preparedness from the
perspective of the participant. Each
participant will be surveyed three times,
once before and twice after their
participation in the Personal
Preparedness Workshop.
It is estimated that there will be a total
of 600 respondents per year with an
estimated time for data collection of
twenty minutes each on the Preworkshop survey, five minutes each on
the Ready CDC Workshop Evaluation,
and ten minutes each on the Follow-Up
Survey.
Instruments will be administered
electronically (by including a link to the
survey Web site with the email
invitation) with an option for paper
copy administration. The Follow-Up
Survey will be used to document
changes in the categories of questions
dealing with preparedness from the
initial pre-workshop survey.
The estimated total time for data
collection is 35 minutes, resulting in an
annualized estimated burden of 350
hours.
There are no costs to respondents
except their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
ehiers on DSK2VPTVN1PROD with NOTICES
Type of respondent
Form name
CDC Federal Employees and Contractors .....
CDC Federal Employees and Contractors .....
CDC Federal Employees and Contractors .....
Pre-Workshop Survey ....................................
Ready CDC Workshop Evaluation .................
Follow-Up Survey ...........................................
VerDate Mar<15>2010
14:53 May 08, 2014
Jkt 232001
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
E:\FR\FM\09MYN1.SGM
Number of
responses per
respondent
600
600
600
09MYN1
1
1
1
Average
burden per
response
(in hours)
20/60
5/60
10/60
]]>Agencies
[Federal Register Volume 79, Number 90 (Friday, May 9, 2014)]
[Notices]
[Pages 26760-26762]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-10618]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-14-0904]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
SEARCH for Diabetes in Youth Study (OMB No. 0920-0904, exp. 11/30/
2014)--Revision--National Center for Chronic Disease Prevention and
Health
[[Page 26761]]
Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Diabetes is one of the most common chronic diseases among children
in the United States. Reports of increasing frequency of both type 1
and type 2 diabetes in youth have been among the most concerning
aspects of the evolving diabetes epidemic. In response to this growing
public health concern, the Centers for Disease Control and Prevention
(CDC) and the National Institutes of Health (NIH) funded the SEARCH for
Diabetes in Youth Study.
The SEARCH for Diabetes in Youth Study began in 2000 as a multi-
center, epidemiological study, conducted in six geographically
dispersed clinical study centers that reflected the racial and ethnic
diversity of the U.S. Phases 1 (2000-2005) and 2 (2005-2010) produced
estimates of the prevalence and incidence of diabetes among youth age
<20 years, according to diabetes type, age, sex, and race/ethnicity,
and characterized selected acute and chronic complications of diabetes
and their risk factors, as well as the quality of life and quality of
health care. In Phases 1 and 2, the clinical centers and a data
coordinating center were funded through cooperative agreements. The
information collected at that time was not provided directly to CDC.
Phase 3 (2011-present) builds upon previous efforts. Five clinical
sites collect patient-level information that is compiled by a data
coordinating center. CDC obtained OMB approval to receive the
information in 2011 (SEARCH for Diabetes in Youth, OMB No. 0920-0904,
exp. 11/30/2014). Phase 3 includes a case registry of youth <20 years
of age who have been diagnosed with diabetes, and a longitudinal cohort
research study about SEARCH cases whose diabetes was incident in 2002
or later. To date, SEARCH Phase 3 has identified an average of 1,361
incident cases of diabetes among youth under 20 years each year of the
study and has completed an average of 1,088 participant surveys each
year (80% participation rate among registry study participants). As of
November 2013, SEARCH Phase 3 has completed visits for 1,839 cohort
study participants.
CDC plans to continue information collection for two additional
years, with minor changes. Participants in the registry study will
continue to complete a Medication Inventory and an Initial Participant
Survey; however, the in-person study examination will be discontinued.
This change will result in a decrease in burden per respondent. CDC
estimates that each clinical site will identify and register an average
of 255 cases per year, for a total 1,275 cases across all sites.
No data collection changes are planned for the cohort study. CDC
estimates that each clinical site will conduct follow-up on an average
of 142 cases per year, for a total of 710 cases across all sites. The
items collected for each case include a Health Questionnaire (Youth
version), an additional Health Questionnaire (Parent version), Center
for Epidemiologic Study-Depression, Quality of Care, Pediatric Quality
of Life Survey (Peds QL), SEARCH Michigan Neuropathy Screening
Instrument, Diabetes Eating Survey, Low Blood Sugar Survey,
Supplemental Survey, Tanner Stage, Retinal Photo, Family Conflict
Survey, Pediatric Diabetes Quality of Life Scale, Physical Exam,
Specimen Collection, and Food Frequency Questionnaire.
Findings from the registry study will be used to estimate the
incidence of diabetes in youth in the U.S. Findings from the cohort
study will be used to estimate the prevalence and incidence of risk
factors and complications associated with diabetes in youth, including
chronic microvascular complications (retinopathy, nephropathy, and
autonomic neuropathy) and selected markers of macrovascular
complications (hypertension, arterial stiffness) of diabetes.
Participation is voluntary and there are no costs to respondents
other than their time. The total estimated annualized burden hours are
4,248.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hr)
----------------------------------------------------------------------------------------------------------------
SEARCH Registry Study Participants.... Medication Inventory.... 1,275 1 5/60
Initial Participant 1,275 1 10/60
Survey.
SEARCH Cohort Study Participants...... Health Questionnaire- 710 1 15/60
Youth.
Health Questionnaire- 710 1 15/60
Parent.
CES-Depression.......... 710 1 4/60
Quality of Care......... 710 1 13/60
Peds QL................. 710 1 5/60
SEARCH MNSI Neuropathy.. 710 1 10/60
Diabetes Eating Survey.. 710 1 5/60
Low Blood Sugar Survey.. 710 1 5/60
Supplemental Survey..... 710 1 10/60
Tanner Stage............ 710 1 5/60
Retinal Photo........... 710 1 15/60
Family Conflict Survey.. 710 1 5/60
Pediatric Diabetes QOL 710 1 5/60
Scale.
Physical Exam........... 710 1 3
Specimen Collection..... 710 1 20/60
Food Frequency 710 1 20/60
Questionnaire.
----------------------------------------------------------------------------------------------------------------
[[Page 26762]]
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-10618 Filed 5-8-14; 8:45 am]
BILLING CODE 4163-18-P
